Cidara Therapeutics: Q4 Earnings Snapshot

Published March 23, 2023 4:32 AM

SAN DIEGO (AP) — SAN DIEGO (AP) — Cidara Therapeutics Inc. (CDTX) on Thursday reported a loss of $13.4 million in its fourth quarter.

On a per-share basis, the San Diego-based company said it had a loss of 19 cents.

The biopharmaceutical company posted revenue of $10.2 million in the period.

For the year, the company reported that its loss narrowed to $29.8 million, or 43 cents per share. Revenue was reported as $64.3 million.

The company’s shares closed at $1.90. A year ago, they were trading at 82 cents.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDTX at https://www.zacks.com/ap/CDTX

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KION 46 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.